cached image

Douglas R. Galasko, MD

Neuroscience University of California, San Diego, La Jolla, CA 
"Douglas Galasko"

Mean distance: 19.84 (cluster 32)
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Thomas KR, Bangen KJ, Edmonds EC, et al. (2021) Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12238
Gate D, Tapp E, Leventhal O, et al. (2021) CD4 T cells contribute to neurodegeneration in Lewy body dementia. Science (New York, N.Y.). eabf7266
Edmonds EC, Smirnov DS, Thomas KR, et al. (2021) Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes. Neurology
Salloway S, Farlow M, McDade E, et al. (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine
Bangen KJ, Thomas KR, Weigand AJ, et al. (2021) Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Barker MS, Manoochehri M, Rizer SJ, et al. (2021) Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 139: 99-115
Caldwell AB, Liu Q, Schroth GP, et al. (2020) Dedifferentiation and neuronal repression define familial Alzheimer's disease. Science Advances. 6
Marshall GA, Sikkes SAM, Amariglio RE, et al. (2020) Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12118
Sandau US, Wiedrick JT, Smith SJ, et al. (2020) Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad
Weigand AJ, Bondi MW, Thomas KR, et al. (2020) Association of anticholinergic medication and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology
See more...